ABSTRACT
Purpose: To explore the potential impact of traditional Chinese herb FuZhengHuaYuJiangZhuTongLuo recipe (FZHY) on renal interstitial fibrosis (RIF) in chronic kidney disease (CKD) at cellular and molecular levels.
Methods: Unilateral ureteral obstruction (UUO) rats were established as the RIF model in vivo. The rats were given intragastric administration with FZHY once a day for consecutive 7, 14 and 21 days, respectively. The renal function parameters and inflammation indicators in kidney tissues were measured using enzyme-linked immunosorbent assay, the CD4+/CD8+ T cells in peripheral blood was detected using flow cytometry, the renal fibrosis degree was estimated using Masson’s staining, and the fibrosis-related genes’ expression was detected using quantitative polymerase chain reaction, western blotting, and immunohistochemistry analyses.
Results: FZHY prescription reduced the serum creatinine and blood urea nitrogen, decreased the levels of c-reactive protein, interleukin-1, interleukin-6 and tumor necrosis factor-α in kidney tissues, and increased the ratio of CD4+/CD8+ T cells in peripheral blood. FZHY prescription suppressed the renal tissue fibrosis and reduced the levels of laminin, fibronectin, collagen I and collagen III.
Conclusions: FZHY prescription suppressed the renal fibrosis and improved the condition of “Healthy Qi Deficiency and Evil Qi Excess” in rats with UUO, which may provide an effective method for CKD treatment.
Key words
FZHY; Chronic kidney disease; Fibrosis; Inflammation; CD4 Antigens; CD8 Antigens
Thumbnail
Thumbnail
Thumbnail
Thumbnail
Thumbnail
FZHY: FuZhengHuaYuJiangZhuTongLuo recipe; UUO: unilateral ureteral obstruction; *P < 0.05, **P < 0.01 UUO group vs. sham group; #P < 0.05, ##P < 0.01, UUO + FZHY group vs. UUO group; DP < 0.05; DDP < 0.01; ns: not significant; UUO + AST-120 group vs. UUO + FZHY group; G: glomerulus; ▲: dilatated tubule; ★: tubule. Scale bar: 50 μm.
FZHY: FuZhengHuaYuJiangZhuTongLuo recipe; UUO: unilateral ureteral obstruction; CRP: C-reactive protein; IL-1: interleukin-6; IL-6: interleukin-6; TNF-α: tumor necrosis factor-α; *P < 0.05; **P < 0.01 UUO group vs. sham group; #P < 0.05; ##P < 0.01; NS: not significant; UUO + FZHY group vs. UUO group; DP < 0.05; DDP < 0.01; ns: not significant; UUO + AST-120 group vs. UUO+FZHY group.
FZHY: FuZhengHuaYuJiangZhuTongLuo recipe; UUO: unilateral ureteral obstruction; *P < 0.05; **P < 0.01; ns: not significant.
FZHY: FuZhengHuaYuJiangZhuTongLuo recipe; UUO: unilateral ureteral obstruction; **P < 0.01, UUO group vs. sham group; #P < 0.05; ##P < 0.01, UUO+FZHY group vs. UUO group; D P < 0.05, UUO+AST-120 group vs. UUO+FZHY group; ns: not significant.
FZHY: FuZhengHuaYuJiangZhuTongLuo recipe; UUO: unilateral ureteral obstruction; G: glomerulus; : dilatated tubule; : tubule. Scale bar: 50 μm.